Infectious Disease

A Wealth of Experience

We have collaborated with our clients on projects to research infectious disease, infectious disease treatment, and complications and comorbidities of infectious disease.  Our experience includes:

  • Cholera
  • H1N1
  • Hepatitis
  • Herpes
  • HIV/AIDS
  • Hospital-acquired infections
  • Human papillomavirus
  • Influenza
  • Invasive fungal infections
  • Malaria
  • Meningococcal disease
  • MRSA
  • Respiratory tract infections
  • Respiratory syncytial virus (RSV)
  • STDs
  • Vaccines

Types of Projects

We have implemented studies to help our clients develop strategies in the infectious disease market and to develop and gain market access for products to treat infectious diseases and complications arising from treatment of infectious diseases.

Recent projects have included:

Our Experts

Alejandro Arana Navarro
Director, Epidemiology
Alicia Gilsenan
Senior Director, Epidemiology
Sandra Talbird
Senior Director, Health Economics
Marco Boeri
Senior Research Economist
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Michele Wilson
Director, Health Economics
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Jin Yang
Sr. Associate, Market Access and Outcomes Strategy
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Maria Fernandez
Director, Market Access and Outcomes Strategy
Juliana Meyers
Director, Health Economics
Whitney Krueger
Research Epidemiologist
Samantha Kurosky
Director, Health Economics
Katherine Hicks
Director, Health Economics
Elizabeth Andrews
Vice President, Pharmacoepidemiology and Risk Management
Jonathan Graham
Director, Health Economics
Stephanie Earnshaw
Vice President, Health Economics
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Bintu Sherif
Senior Statistician
Keith Davis
Senior Director, Health Economics
Annete Njue
Director, Market Access and Outcomes Strategy
Christine Poulos
Senior Research Economist
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Susan Hogue
Head, Value Insight and Access Strategy
Will Herring
Director, Health Economics
Josephine Mauskopf
Vice President, Health Economics
Catherine Masaquel
Director, Market Access and Outcomes Strategy

Selected Recent Infectious Disease Publications